Standout Papers

mRNA-based therapeutics — developing a ... 1997 2026 2006 2016 1.6k
  1. mRNA-based therapeutics — developing a new class of drugs (2014)
    Uğur Şahin, Katalin Karikó et al. Nature Reviews Drug Discovery
  2. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening (1997)
    Yao‐Tseng Chen, Matthew J. Scanlan et al. Proceedings of the National Academy of Sciences
  3. Mutant MHC class II epitopes drive therapeutic immune responses to cancer (2015)
    Sebastian Kreiter, Mathias Vormehr et al. Nature
  4. Personalized vaccines for cancer immunotherapy (2018)
    Uğur Şahin, Özlem Türeci Science
  5. Exploiting the Mutanome for Tumor Vaccination (2012)
    John C. Castle, Sebastian Kreiter et al. Cancer Research
  6. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera (2021)
    Alexander Muik, Ann-Kathrin Wallisch et al. Science
  7. A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis (2021)
    LAURA D. KOLB, Thomas Bukur et al. Science
  8. Identification of neoantigens for individualized therapeutic cancer vaccines (2022)
    Franziska Lang, Barbara Schrörs et al. Nature Reviews Drug Discovery
  9. mRNA therapeutics in cancer immunotherapy (2021)
    Jan D. Beck, Nadja Salomon et al. Molecular Cancer
  10. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera (2022)
    Alexander Muik, Bonny Gaby Lui et al. Science
  11. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies (2017)
    Christiane Stadler, Hayat Bähr-Mahmud et al. Nature Medicine
  12. The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines (2022)
    Gary R. McLean, Jeremy P. Kamil et al. mBio

Immediate Impact

46 by Nobel laureates 34 from Science/Nature 205 standout
Sub-graph 1 of 20

Citing Papers

Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
23 intermediate papers

Works of Özlem Türeci being referenced

A liposomal RNA vaccine inducing neoantigen-specific CD4 + T cells augments the antitumor activity of local radiotherapy in mice
2020
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
2015 StandoutNature
and 9 more

Author Peers

Author Last Decade Papers Cites
Özlem Türeci 7200 8427 4324 178 14.5k
Eli Gilboa 10375 11355 5975 183 19.7k
Karl‐Peter Hopfner 6733 11115 2391 176 16.7k
Gerd Ritter 9098 5493 5333 181 14.1k
Gary A. Koretzky 12952 8366 3736 207 20.4k
Volker Schirrmacher 6791 4935 4817 393 14.6k
Thomas Tursz 5660 7216 5771 194 16.1k
Pamela L. Schwartzberg 11071 4886 3661 151 17.4k
Ivan D. Horak 5620 4798 3861 204 13.8k
Nancy Hogg 11173 7144 2371 200 20.7k
Melvyn F. Greaves 7707 5570 2024 183 17.6k

All Works

Loading papers...

Rankless by CCL
2026